Cheng Sohanya Roshan
SEC CIK 1865796 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | SVP Sales, Commercial Ops | 107.9K | — | $162.0K | 21 | 2021-06-30 | 2026-05-14 |
Most active insiders at KPTI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Paulson Richard A. | Pres, CEO, Dir | — | $137.2K |
| 2 | Poulton Stuart | EVP, Chief Development Off | — | $56.4K |
| 3 | Rangwala Reshma | EVP, Chief Medical Off | — | $55.6K |
| 4 | Cheng Sohanya Roshan | EVP, Chief Commercial Off | — | $46.4K |
| 5 | Mano Michael | SVP, GC, Sec | — | $35.7K |
| 6 | Macomber Lori | EVP, CFO, Treas | — | $10.2K |
| 7 | Abate Kristin | CAO | — | $10.0K |
| 8 | Su Zhen | Dir | — | — |
| 9 | Oliger Christy J. | Dir | — | — |
| 10 | Schor Chen | Dir | — | — |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 16:05 | 2026-05-13 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | A - Grant | $0.00 | +947 | 108.3K | +0.9% | $0 | |
| 2026-05-15 16:05 | 2026-05-14 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | S - Sale | $9.50 | -324 | 107.9K | -0.3% | -$3,078 | |
| 2026-03-03 | 2026-03-02 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | S - Sale | $9.41 | -4,604 | 107.3K | -4% | -$43.3K | |
| 2026-02-03 | 2026-01-31 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | A - Grant | $0.00 | +32.4K | 111.9K | +41% | $0 | |
| 2025-10-16 | 2025-10-15 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | A - Grant | $0.00 | +43.6K | 79.5K | +122% | $0 | |
| 2025-09-16 | 2025-09-12 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | A - Grant | $0.00 | +945 | 36.2K | +3% | $0 | |
| 2025-09-16 | 2025-09-15 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | S - Sale | $6.43 | -325 | 35.9K | -0.9% | -$2,090 | |
| 2025-03-06 | 2025-03-04 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | S - Sale | $6.29 | -3,445 | 34.3K | -9% | -$21.7K | |
| DM | 2025-03-04 | 2025-02-28 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | A - Grant | $0.00 | +9,999 | 37.8K | +36% | $0 |
| 2024-09-05 | 2024-09-04 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | S - Sale | $0.72 | -5,356 | 404.1K | -1% | -$3,856 | |
| M | 2024-03-04 | 2024-02-29+ | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | S - Sale | $1.18 | -26.9K | 393.5K | -6% | -$31.7K |
| 2024-02-29 | 2024-02-28 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | A - Grant | $0.00 | +199.0K | 420.5K | +90% | $0 | |
| 2024-01-25 | 2024-01-24 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | A - Grant | $0.00 | +14.2K | 221.5K | +7% | $0 | |
| 2023-09-05 | 2023-09-01 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | S - Sale | $1.33 | -7,415 | 204.1K | -4% | -$9,862 | |
| 2023-06-12 | 2023-06-08 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | S - Sale | $2.35 | -1,839 | 211.5K | -0.9% | -$4,322 | |
| 2023-03-02 | 2023-03-01 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | S - Sale | $3.03 | -11.2K | 210.7K | -5% | -$34.1K | |
| 2023-03-02 | 2023-02-28 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | A - Grant | $0.00 | +100.0K | 221.9K | +82% | $0 | |
| D | 2022-09-01 | 2022-08-31 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | EVP, Chief Commercial Off | A - Grant | $0.00 | +30.0K | 119.9K | +33% | $0 |
| M | 2022-06-14 | 2022-06-13 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | Chief Commercial Off | S - Sale | $5.21 | -1,551 | 91.4K | -2% | -$8,075 |
| D | 2022-03-02 | 2022-02-28 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | Chief Commercial Off | A - Grant | $0.00 | +84.0K | 91.5K | +1,120% | $0 |
| D | 2021-07-01 | 2021-06-30 | KPTI | Karyopharm Therapeutics Inc. | Cheng Sohanya Roshan | SVP Sales, Commercial Ops | A - Grant | $0.00 | +7,500 | 7,500 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations